Search
Displaying 31–40 of 1130 results
-
Eye on the Cure Podcast | Episode 91: Dr. George Magrath
Eye on the CureDr. George Magrath is the CEO of Opus Genetics, a clinical-stage biopharmaceutical company developing gene and small molecule therapies for vision-threatening eye diseases.
-
From its legendary cowboy culture to world-class art, lush outdoor escapes, and a vibrant food scene, Fort Worth offers something for everyone. Whether you’re exploring the iconic Stockyards, strolling through the Cultural District, or enjoying the city’s lively neighborhoods, you’ll find plenty of ways to make the most of your visit during United in Vision 2026.
-
Postdoctoral Fellowship Award guidelines and application details.
-
Overview and application instructions for the Disease Model Award
-
Beacon Stories
Lindsey Rambo once believed treatment was meant for someone else. Today, she’s the first participant in a groundbreaking gene therapy trial for LCA5—and her journey is lighting the way for what’s possible in the future of vision research.
-
Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy
Research NewsThe Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.
-
jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy
Research NewsThe trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.
-
Invisible Disability
You cannot tell by looking at me that I am visually impaired. The #1 reaction to my lack of sight confession, though, hands down, is a nervous laugh followed by the person not believing me.
-
Invisible Disability
When I walk around the neighborhood with my white cane, I still worry about stigma and how people perceive me. I’ve had to remind myself that the cane is a tool to keep me safe.
-
Wellness
One in seven adolescents worldwide suffers from a mental health disorder. Teen therapy can help pacify the disorderly apadation to early adulthood and make it easier.
